ICD-10 Code D47.3 | Essential (hemorrhagic) thrombocythemia Symptoms, Diagnosis, Billing

Essential (hemorrhagic) thrombocythemia is a myeloproliferative neoplasm characterized by an increase in platelet production, leading to a higher risk of thrombosis and hemorrhage. This condition is often idiopathic, though genetic mutations may play a role. Accurate coding with ICD-10 Code D47.3 is crucial for proper diagnosis, documentation, billing, and public health reporting, ensuring that patients receive appropriate management and follow-up.

What is ICD-10 Code D47.3 for Essential (hemorrhagic) thrombocythemia?

ICD-10 Code D47.3 represents Essential (hemorrhagic) thrombocythemia, a condition marked by excessive platelet production that can lead to complications such as thrombosis or bleeding. This code should be used in clinical documentation and billing when diagnosing patients with this myeloproliferative disorder, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.

ICD-10 Code D47.3 – Clinical Definition and Explanation of Essential (hemorrhagic) thrombocythemia

Essential (hemorrhagic) thrombocythemia is caused by abnormal proliferation of megakaryocytes in the bone marrow, leading to elevated platelet counts. The condition can progress to serious complications, including thrombotic events and hemorrhagic episodes, necessitating medical intervention.

Key Clinical Features:

• Elevated platelet count often exceeding 450,000/µL.
• Symptoms may include headaches, dizziness, and visual disturbances.
• Increased risk of thrombotic events such as stroke or myocardial infarction.
• Potential for bleeding complications due to platelet dysfunction.

ICD-10 Code D47.3 for Essential (hemorrhagic) thrombocythemia – SOAP Notes & Clinical Use

ICD-10 Code D47.3 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It is relevant in both acute and chronic care settings, facilitating comprehensive patient management and ensuring accurate billing.

What Does ICD-10 Code D47.3 for Essential (hemorrhagic) thrombocythemia Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D47.3 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Essential (hemorrhagic) thrombocythemia. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code D47.3 – Essential (hemorrhagic) thrombocythemia

Management of Essential (hemorrhagic) thrombocythemia often requires hospitalization for severe cases. Treatment focuses on reducing platelet counts and preventing complications.

Antibiotic Therapy:

Supportive Care:

• Hydroxyurea to reduce platelet counts.
• Aspirin for antiplatelet therapy to prevent thrombotic events.
• Regular monitoring of blood counts and symptoms.

Infection Control:

How to Document Symptoms of Essential (hemorrhagic) thrombocythemia (ICD-10 D47.3) in SOAP Notes

Subjective:

• Patient reports frequent headaches and dizziness.
• History of easy bruising and prolonged bleeding.
• No recent infections or significant changes in health status.
• Family history of myeloproliferative disorders.

Objective:

• Platelet count: 600,000/µL.
• Blood pressure: 130/85 mmHg.
• No signs of active bleeding on examination.
• Normal findings on abdominal and neurological exams.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Essential (hemorrhagic) thrombocythemia (ICD-10 Code D47.3)

Assessment:

• Diagnosis: Essential (hemorrhagic) thrombocythemia, moderate severity.
• ICD-10 Code: D47.3.
• Contributing factors: Genetic predisposition and environmental triggers.
• Monitor for thrombotic and hemorrhagic complications.

Plan:

• Initiate hydroxyurea therapy to manage elevated platelet counts.
• Educate patient on recognizing symptoms of thrombosis and bleeding.
• Schedule follow-up in 4 weeks for blood count monitoring.
• Consider referral to hematology for further management.

Treatment & Plan Section for ICD-10 Code D47.3 – Essential (hemorrhagic) thrombocythemia

• Hydroxyurea as first-line pharmacologic treatment.
• Aspirin for prevention of thrombotic events.
• Regular monitoring of complete blood counts.
• Patient education on lifestyle modifications to reduce risk.

Using ICD-10 Code D47.3 for Essential (hemorrhagic) thrombocythemia in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings.
• Use D47.3 in appropriate clinical settings for billing.
• Align treatment plans with clinical guidelines for justified billing.
• Document any comorbidities or complications to support claims.

Related ICD-10 Codes Often Used with Essential (hemorrhagic) thrombocythemia

• D47.1 – Polycythemia vera
• D47.2 – Essential thrombocythemia

ICD-10 Code D47.3 in Medical Billing and Insurance for Essential (hemorrhagic) thrombocythemia

ICD-10 Code D47.3 is essential for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings to support the diagnosis.
• Use D47.3 in inpatient and outpatient settings for appropriate reimbursement.
• Ensure that treatment plans are clearly outlined in the medical record.
• Include any relevant lab results to substantiate the diagnosis.

Common CPT Pairings: